How DCN Dx Helped a Startup Stabilize Their Assay and Move Forward with Confidence
In this case study, a diagnostics startup came to DCN Dx after months of frustration with their previous development partner. The program had stalled. Documentation was lacking. The assay wasn’t reproducible. And forward progress seemed out of reach.
DCN Dx took over the project, stabilized the design, and advanced it through Phase 2 optimization and development. The team addressed gaps in technical documentation, improved formulation consistency, and prepared the assay for analytical and clinical validation. The result: a product finally back on track, with a clear path to regulatory submission.
This case study highlights the value of having the right technical partner when your program hits a wall.
WHY READ
If you’re working on an assay development program that’s stalled or gone sideways, this case study shows how DCN Dx can help:
- Stabilize and optimize inherited designs with limited documentation.
- Restore reproducibility and correct performance gaps.
- Move stalled assays into Phase 2 development and validation.
- Deliver the technical clarity and support needed to move forward.
- Avoid further delays by partnering with a team that knows how to get results.
